Isogenica

Welcome to Isogenica

 

Isogenica is at the forefront of synthetic biology, pursuing a mission to provide the fastest, most efficient engine for therapeutic antibody discovery

Read More

 

Events
News

10
Oct

Bio-Europe 2019, Vienna

Vienna, Austria | 25th March–27th 2019
 
Isogenica is excited to be attending Bio-Europe this year. 

Read More
27
Mar

12th Annual Proteins & Antibodies Congress 2019

London, UK | 24th-25th April 2019

 
Isogenica will be speaking about VHH single domain antibodies generated from our LlamdA library.

Read More

7
Jan

Isogenica expands collaboration with Aro Biotherapeutics

Cambridge, UK, 7th January 2019

 

Today, Isogenica have announced an expansion of the collaboration and license agreement signed with Aro Biotherapeutics

 

Read More
22
Aug

Isogenica appoints Dr Emma Sceats as Chief Executive Officer

Cambridge, UK, 3rd September 2018

 

Isogenica CEO will join Isogenica’s Board of Directors with immediate effect.

 

Read More